E2F transcription factors play a central role in coordinating cell cycle progression by regulating the transcription of genes required for the cell cycle, particularly those genes involved in the G1 to S phase transition (Dyson, 1998; Stevens and La Thangue, 2003a) . E2F activity is integrated with the pocket protein family, exemplified by the retinoblastoma tumour suppressor protein, which bind to certain E2F subunits, thereby regulating transcriptional activity. Since pocket protein activity is controlled in part through phosphorylation by cyclin-dependent kinase complexes (cdk), E2F serves to integrate the cell cycle machinery with the transcription apparatus. Most importantly, the pathway involved in E2F control becomes aberrant in most, if not all, human tumour cells either through mutation in the pRb gene, or through altered cdk activity, events that lead to increased E2F activity (Hanahan and Weinberg, 2000) .
E2F genes are evolutionarily conserved. In mammalian cells, E2F activity exists as an E2F/DP heterodimer involving one of six E2F bound to one of two DP family members (Stevens and La Thangue, 2003a) . The most recently identified member of the family, E2F-7, binds to DNA in a DP-independent manner (DeBruin et al., 2003; Di Stefano et al., 2003; Logan et al., 2004) . Moreover, there is increasing evidence that different E2F and DP subunits perform distinct, perhaps overlapping, roles (Trimarchi and Lees, 2002 ). This view is well supported by the phenotype of E2F-1 À/À mice, which exhibit defects in apoptosis and increased tumour incidence (Yamasaki et al., 1996) , and the accumulating evidence, which supports a role of E2F-1-dependent apoptosis in the checkpoint response to DNA damage (Blattner et al., 1999; Stevens et al., 2003; Stevens and La Thangue, 2003b) . Further, the genetic inactivation of other E2F subunits yields markedly distinct phenotypes from E2F-1 À/À mice (Trimarchi and Lees, 2002) . The E2F-7 protein is a particularly interesting member of the E2F family. In contrast to other E2F subunits, E2F-7 possesses two distinct DNA-binding domains, the integrity of both domains being required for DNA-binding activity (DeBruin et al., 2003; Logan et al., 2004) . E2F-7 acts to repress the transcription of E2F target genes and prevents cell cycle progression. The presence of two DNA-binding domains, combined with the lack of requirement for a DP partner, suggests that E2F-7 performs a physiological role that is distinct from the other E2F subunits. Interestingly, the general organization of E2F-7 is shared with several plant E2F-like (E2FL) proteins, which similarly contain two DNAbinding domains (Kosugi and Ohashi, 2002) . Like mammalian E2F-7, the plant E2L proteins repress transcription, and recent evidence suggests that they perform a specialized role in the plant cell cycle (Vlieghe et al., 2005) .
In this study, we report the characterization of a new E2F family, referred to as E2F-8, which exhibits striking similarity in both its organization and functional properties to E2F-7. Particularly, E2F-8 contains two DNA-binding domains. Furthermore, E2F-8 represses transcription and delays cell cycle progression. The similarities between E2F-7 and E2F-8 define a new subgroup of the E2F family, and suggest that E2F-7 and E2F-8 may act through a shared mechanism in cell cycle control.
The complete human E2F-8 sequence contains 867 amino-acid residues (Figure 1a ). The murine E2F-8 sequence is 860 residues and has 82% identity to the human sequence (Figure 1a) . Two domains in E2F-8 exhibit significant similarity with the DNA-binding domains of other members of the E2F family, referred to as domains 1 and 2 (residues 126-219, and 260-359 in human E2F-8) located in the N-terminal half of the protein (Figure 1b) . The E2F-7 subunit possesses the highest overall level of similarity to E2F-8, exhibiting 35% identity when the entire length of the proteins is aligned.
The conserved RRXYD motif, required for DNA binding and conserved across the E2F family (Zheng et al., 1999) , is present in domains 1 and 2 as RRIYD and RRLYD, respectively (Figure 1c) . The similarity between domains 1 and 2 in E2F-7 and E2F-8 extends beyond the core RRXYD motif, covering a total stretch
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, in which either of the core RRXYD DNAbinding motifs were altered to R156A (domain 1) or R314A (domain 2), failed to bind to DNA (Figure 2d ).
We found that E2F-8 fails to activate transcription, and therefore assessed whether E2F-8 could reduce the levels of E2F site-dependent transcription upon activation by E2F-1 as reported previously for E2F-7 (Logan et al., 2004) . There was a decrease in transcription when E2F-8 was coexpressed with E2F-1 on diverse E2F-regulated promoters, including Apaf1 and adenovirus E2A (Figure 3) . The reduction in E2F-1-dependent transcription required the integrity of both domains 1 and 2, since the mutant derivatives with either single (R156A or R3145A) or double mutant (R156A/R314A), which fail to bind to DNA (Figure 2d ) had an insignificant effect on transcription (Figure 3) . This was not due to reduced protein expression since R156A, R314A and R156A/R314A were expressed at similar levels to wild-type E2F-8 (Figure 3) . Thus, E2F-8 can modulate E2F-dependent transcription, and DNAbinding activity is necessary for this effect of E2F-8.
Previous studies indicated that E2F-7 can delay cell cycle progression, causing an increase in the proportion of cells in G1 (Logan et al., 2004) . We investigated whether E2F-8 could affect cell cycle progression by introducing E2F-8 into HeLa cells that were subsequently released into S phase after hydroxyurea arrest (1 mg) as indicated with the pE2A-luc reporter construct (1 mg) and pCMV-bgal (1 mg) as described previously (Chan et al., 2001; Stevens et al., 2003; Logan et al., 2004) . The data represent the ratio of luciferase to bgal activity. (b) U2OS cells were transfected with E2F-7 (0.5 mg), E2F-8 (0.5 mg) or R314A as indicated together with pApaf1-luc and pCMV-bgal (1 mg) as described previously. The reporter constructs have been described previously (Moroni et al., 2001; Stevens et al., 2003) . (c) Protein extracts from the above-transfected cells were immunoblotted with the appropriate antibodies to establish the levels of E2F-8, R156A, R314A and R156A/R314A a b Figure 4 Growth-regulating properties of E2F-8 Flow cytometry on HeLa cells that were released into S phase for 3.0 h after hydroxyurea treatment (2 mM for 16 h). Cells were transfected with expression vectors encoding E2F-7 (10 mg), E2F-8 (10 mg) or E2F-8 R145/314A (10 mg), which were performed as described previously (Zhao et al., 2004) . The level of G1, S and G2/M phase cells is indicated in (a). The graph (b) represents the relative difference of cells treated with either E2F-7, E2F-8 or E2F-8 R145/304A to the control cells treated with pCDNA alone A new E2F subunit E2F-8 N Logan et al (Zhao et al., 2004) . Under these conditions, E2F-8, like E2F-7, caused a significant increase in G1 cells (Figure 4) . That the delay in cell cycle progression required a functional E2F-8 protein was confirmed by studying the properties of the E2F-8 R156A/314A, which failed to delay cell cycle progression in HeLa cells (Figure 4) . These results indicate that E2F-8 can negatively regulate cell cycle progression.
Based upon the characterization reported here, E2F-7 and E2F-8 share a number of significant features. The most striking is the presence of two DNA-binding domains, the integrity of each domain being required for DNA-binding activity with the E2F site. Furthermore, both E2F-7 and E2F-8 downregulate transcription and delay cell cycle progression. Owing to these similarities, particularly the notable conservation in the organization of the DNA-binding domains, E2F-7 and E2F-8 constitute a new subgroup of the E2F family.
Sequence comparison with other members of the E2F family indicated that the core DNA recognition motif, RRXYD, which makes DNA base contact within the E2F binding site (Zheng et al., 1999) , is conserved in E2F-8. Interestingly, while both domains exhibit similarity outside this core motif, domain 2 rather than domain 1 exhibits a greater degree of similarity across the E2F family, which was also noted in the sequence of E2F-7 (Logan et al., 2004) . Of further interest is the spacing between domains 1 and 2, which is comparable in E2F-7 and E2F-8, and corresponds to about 160 residues. Owing to these shared properties, it is possible that E2F-7 and E2F-8 act through a common mechanism in cell cycle control. Such a shared role may be, for example, in the regulation of an overlapping group of E2F target genes; future experiments will clarify this possibility.
The properties of E2F-7 and E2F-8 resemble those of several plant E2FL proteins identified in Arabidopsis ( Kosugi and Ahashi, 2002) . The plant E2FL proteins exhibit a similar structural organization in the presence of two DNA-binding domains, which are also required for transcriptional repression. In Arabidopsis, the E2L proteins appear to act in regulating the mitotic cell cycle by preventing entry into the endocycle (Vlieghe et al., 2005) . A possible implication from these plant studies is that E2L-like proteins in other phyla act similarly in regulating genes required for the endocycle. While further experiments are required to explore this idea, it is nonetheless possible that the role of E2F-7 and E2F-8 in mammalian cells is related to that concluded from studies in plants.
